Document Detail


Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
MedLine Citation:
PMID:  20938374     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: : Anogenital warts are a common sexually transmitted disease caused by human papillomaviruses. Despite the fact, that imiquimod and podophyllotoxin represent common topical agents, direct comparative studies lack. This work compares the effectiveness and safety of self-applied imiquimod 5% cream and podophyllotoxin 0.5% solution.
METHODS: : Within 2 years, consecutive patients presenting with untreated anogenital warts were included in a randomized, open label trial. The primary endpoint was complete clearance at the end of treatment (4 weeks after the start with podophyllotoxin, 16 weeks after the start of imiquimod therapy). Side effects were evaluated as a secondary endpoint.
RESULTS: : A total of 45 patients, 7 women and 35 men, of whom 5 were circumcised, concluded the treatment and were eligible for evaluation. The rates of clearance of baseline warts among treatment groups were 72% (95% confidence interval [CI], 52%-86%) in the podophyllotoxin group and 75% (95% CI, 53%-98%) in the imiquimod group. Statistically, clearance rates were identical (P = 1). The differences in side effects between treatment groups were statistically not significant (P = 0.24).
CONCLUSIONS: : The current study, a direct comparison of both, confirms the previously obtained mathematical data, that imiquimod 5% cream and podophyllotoxin 0.5% solution have an identical beneficial effect on anogenital warts and are associated with identical and acceptable side effects. Both substances constitute effective and safe treatments of untreated anogenital warts in immunocompetent individuals.
Authors:
Peter Komericki; Merve Akkilic-Materna; Tanja Strimitzer; Werner Aberer
Related Documents :
6191504 - Short-wave ultraviolet light (uvb) treatment of allergic contact dermatitis of the hands.
23222394 - High-density silicone oil densiron-68 as an intraocular tamponade for primary inferior ...
19594764 - A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of pa...
20886224 - Long-term outcome after treatment with 5% topical imiquimod cream in patients with basa...
20837254 - Use of antivenom for snakebites reported to united states poison centers.
2046134 - Analysis and interpretation of treatment effects in subgroups of patients in randomized...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Sexually transmitted diseases     Volume:  38     ISSN:  1537-4521     ISO Abbreviation:  Sex Transm Dis     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7705941     Medline TA:  Sex Transm Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  216-8     Citation Subset:  IM    
Affiliation:
From the *Department of Environmental Dermatology and Venereology, Medical University of Graz, Graz, Austria; and †Austrian Agency for Health and Food Safety, Data collection, statistics and risk assessment, Graz, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatitis C Prevalence Among HIV-Positive MSM in San Francisco: 2004 and 2008.
Next Document:  Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae and repeat infection among pregnant ur...